Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02964520 · ClinicalTrials.gov registry record · NA
EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety
A NA study of Anxiety, sponsored by University of Hartford.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT02964520: Completed NA study of Anxiety, sponsored by University of Hartford.
NCT02964520 is a NA study of Anxiety that has completed, run by University of Hartford. The registered enrollment target is 28 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02964520, a NA study of Anxiety, has completed, sponsored by University of Hartford.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates if individuals with moderate to high trait anxiety can learn how to self-regulate their brain waves and reduce their trait anxiety in ten sessions of EEG alpha-theta neurofeedback training. Half of the randomly assigned participants will receive alpha/theta neurofeedback training while the other half will receive a two-part control protocol where low beta and beta waves will be uptrained in and downtrained in in successive sessions.
Primary Outcome
Change from baseline of symptoms of anxiety to end of treatment after 4-5 weeks. The STAI scale consists of total 40 items on separate scales measuring state (20 items) and trait (20 items) anxiety. The participant reports how they feel right now at this moment for state anxiety and how they generally feel for trait anxiety. The state items are scored as: 1 (not at all), 2 (somewhat true), 3 (moderately true), 4 (very true). The trait items are scored as: 1 (almost never), 2 (sometimes), 3 (ofte
Conditions Studied
Interventions
- BEHAVIORAL Neurofeedback training
- BEHAVIORAL Sham comparator: Sham neurofeedback training
Study Locations (1)
Connecticut
- University of Hartford - West Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT02964520 record still lists
NCT02964520 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Neurofeedback training is the first listed.
NCT02964520 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02964520 about?
NCT02964520 is a clinical study titled "EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety". This study evaluates if individuals with moderate to high trait anxiety can learn how to self-regulate their brain waves and reduce their trait anxiety in ten sessions of EEG alpha-theta neurofeedback training. Half of the randomly assigned participants will receive alpha/theta neurofeedback trainin...
What is the current status of trial NCT02964520?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-07. Estimated completion is 2017-01.
What conditions does trial NCT02964520 study?
This clinical trial studies the following conditions: Anxiety.
What interventions are being tested in trial NCT02964520?
The interventions under investigation include: Neurofeedback training (BEHAVIORAL), Sham comparator: Sham neurofeedback training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02964520?
This trial is sponsored by University of Hartford, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02964520 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anxiety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02964520's enrollment target sits among peer trials
28 313th of 364 higher than 51 of 364 other Anxiety trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anxiety trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia